等待開盤 09-24 09:30:00 美东时间
-0.370
-2.87%
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.2% on Tuesday. Shares of Telefonaktiebolaget LM Ericsson – ADR (NASDAQ:ERIC) fell sharply in pre-market trading. Morgan Stanley analyst Terrance Tsul downgraded the stock from Equal-Weight to Underweight and slashed th...
09-22 20:01
U.S. stocks were mixed, with the Dow Jones index gaining around 150 points on Monday. Shares of Napco Security Technologies Inc (NASDAQ:NSSC) rose sharply after the company reported better-than-expected fourth-quarter financial results. NAPCO Security reported quarterly earnings of 41 cents per shar...
08-24 22:22
今日重点评级关注:康托·菲茨杰拉德:维持Ultragenyx Pharmaceutical"超配"评级,目标价从96美元升至103美元;Canaccord Genuity:维持Ultragenyx Pharmaceutical"买入"评级,目标价从81美元升至83美元
08-21 11:40
Citigroup analyst Peter Christiansen maintains Alight (NYSE:ALIT) with a Neutral and lowers the price target from $20 to $16.
08-21 02:48
NEW YORK, Aug. 18, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Alight, Inc. (NYSE: ALIT) breached thei...
08-19 05:08
华盛资讯8月5日讯,Alight, Inc. Class A公布2026财年Q2业绩,公司Q2营收5.11亿美元,同比下降3.2%,归母净利润亏损0.10亿美元,同比亏损缩窄99.1%。
08-05 06:41
Alight (NYSE:ALIT) reported quarterly earnings of $0.91 per share which beat the analyst consensus estimate of $0.76 by 19.74 percent. This is a 54.5 percent decrease over earnings of $2.00 per share from the same period last year. The company reported quarterly sales of $511.000 million which beat ...
08-05 04:13
Alight (NYSE:ALIT) sees FY2026 sales of $2.078 billion-$2.098 billion vs $2.147 billion analyst estimate.
08-05 04:09
U.S. stocks were higher, with the Dow Jones index gaining around 600 points on Monday. Shares of CNH Industrial NV (NYSE:CNH) rose sharply during Monday’s session after the company reported better-than-expected second-quarter financial results and raised its FY26 adjusted EPS guidance with its midpo...
08-03 22:00
制药企业CRNX股价狂飙近99%!获福泰制药百亿美元高溢价收购;罕见病药物研究公司AGIO涨18%,核心产品新药申请获FDA受理;基因治疗药物研发企业NGNE涨13%,公司成功完成新一轮融资>>
07-08 19:19